Drug Approval | August 09, 2023
USFDA completes PAD E inspection of Marksans' Goa facility
The inspection was conducted at its Goa, Vema manufacturing facility
The inspection was conducted at its Goa, Vema manufacturing facility
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Subscribe To Our Newsletter & Stay Updated
